Descartes-11 in Patients With Relapsed/Refractory Multiple Myeloma
Clinical trial NCT03994705 · TERMINATED
Trial details
- NCT number
- NCT03994705
- Sponsor
- Cartesian Therapeutics
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-08-01
- Primary completion
- 2021-05-27
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.